AU576914B2 - 5-cyanopyridine-2-diazohydroxide, basic salts thereof - Google Patents

5-cyanopyridine-2-diazohydroxide, basic salts thereof

Info

Publication number
AU576914B2
AU576914B2 AU49835/85A AU4983585A AU576914B2 AU 576914 B2 AU576914 B2 AU 576914B2 AU 49835/85 A AU49835/85 A AU 49835/85A AU 4983585 A AU4983585 A AU 4983585A AU 576914 B2 AU576914 B2 AU 576914B2
Authority
AU
Australia
Prior art keywords
compounds
diazohydroxide
cyanopyridine
basic salts
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU49835/85A
Other languages
English (en)
Other versions
AU4983585A (en
Inventor
David Cureton Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alabama at Birmingham UAB
Original Assignee
University of Alabama UA
University of Alabama at Birmingham UAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Alabama UA, University of Alabama at Birmingham UAB filed Critical University of Alabama UA
Publication of AU4983585A publication Critical patent/AU4983585A/en
Application granted granted Critical
Publication of AU576914B2 publication Critical patent/AU576914B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU49835/85A 1984-11-13 1985-11-13 5-cyanopyridine-2-diazohydroxide, basic salts thereof Ceased AU576914B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/670,203 US4636564A (en) 1984-11-13 1984-11-13 5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use
US670203 1984-11-13

Publications (2)

Publication Number Publication Date
AU4983585A AU4983585A (en) 1986-05-22
AU576914B2 true AU576914B2 (en) 1988-09-08

Family

ID=24689433

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49835/85A Ceased AU576914B2 (en) 1984-11-13 1985-11-13 5-cyanopyridine-2-diazohydroxide, basic salts thereof

Country Status (10)

Country Link
US (1) US4636564A (OSRAM)
EP (1) EP0181636B1 (OSRAM)
JP (1) JPS61158967A (OSRAM)
AT (1) ATE50566T1 (OSRAM)
AU (1) AU576914B2 (OSRAM)
CA (1) CA1255654A (OSRAM)
DE (1) DE3576154D1 (OSRAM)
DK (1) DK159847C (OSRAM)
ES (1) ES8700238A1 (OSRAM)
ZA (1) ZA858315B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816468A (en) * 1984-11-13 1989-03-28 The University Of Alabama 5-cyanopyridine-2-diazohydroxide, basic salts and use
DE4301109A1 (de) * 1993-01-18 1994-07-21 Bayer Ag Verfahren zur Herstellung von 6-Amino-nicotinsäurenitrilen
ITMI20011495A1 (it) * 2001-07-12 2003-01-12 Pharmaproducts Uk Ltd Sali di calcio ad attivita' citotossica
CN107602456B (zh) * 2017-10-19 2021-04-06 北京印刷学院 偶氮吡啶盐化合物及制备方法

Also Published As

Publication number Publication date
ES8700238A1 (es) 1986-10-01
JPH0146511B2 (OSRAM) 1989-10-09
EP0181636A3 (en) 1987-04-01
DK159847B (da) 1990-12-17
DK159847C (da) 1991-05-13
DK514285D0 (da) 1985-11-07
ZA858315B (en) 1986-10-29
AU4983585A (en) 1986-05-22
ES548791A0 (es) 1986-10-01
ATE50566T1 (de) 1990-03-15
CA1255654A (en) 1989-06-13
DK514285A (da) 1986-05-14
DE3576154D1 (de) 1990-04-05
EP0181636B1 (en) 1990-02-28
US4636564A (en) 1987-01-13
EP0181636A2 (en) 1986-05-21
JPS61158967A (ja) 1986-07-18

Similar Documents

Publication Publication Date Title
HU9401445D0 (en) Nor-bile-acid derivatives, process for producing them and pharmaceutical compositions containing them
ES8600060A1 (es) Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.
IL80495A0 (en) Microbial compositions,their production and their use for treating soil
GEP20033140B (en) Substituted Bicyclic Derivatives Useful as Anticancer Agents
HUT49592A (en) Process for producing bis/hydroxymethyl/-cyclobutyl-purines and pyrimidines, as well as pharmaceutical compositions comprising same
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
CA2047744A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
HUT47123A (en) Process for producing phosphorous compounds and pharmaceutical compositions comprising them as active ingredient, as well as their intermediates
GEP19971030B (en) Method for preparation of derivatives of 1-benzil-3-oximetil-indazolului or salts with pharmaceutically acceptable bases
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
HUT46224A (en) Process for producing pharmaceutical compositions containing prostaglandin e1-derivatives
AU4983585A (en) 5-cyanopyridine-2-diazohydroxide, basic salts thereof
MY101747A (en) Dihydroorotic acids derivative, processes for preparing the same
IE56229B1 (en) 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them
EP0351795A3 (en) Novel deoxyadenosine compounds and methods of making and using the same
AU578125B2 (en) Pyrazine diazohydroxide compounds
HUT47132A (en) Process for producing new 2beta, 16beta-diamono-androstane derivatives and pharmaceutical compositions comprising such compounds
IL74473A0 (en) Salts of oxazaphosphorine derivatives,their production and pharmaceutical compositions containing them
GB2146982B (en) New 1,3,4-thiadiazole derivatives process for the production thereof and pharmaceutical compositions having antiulcer activity containing the same
AU4347389A (en) Novel s-timolol derivative and process for its preparation
ES8601200A1 (es) Un procedimiento para preparar compuestos de 3-(2-haloetil)-4-oxopirazolo-(5, 1-d)-1, 2, 3, 5-tetrazin-8-carboxamida
ES8605261A1 (es) Un procedimiento para la preparacion de 1,4-aminoalquilamino-9-h-tioxaten-9-onas.
ES8605518A1 (es) Procedimiento para preparar derivados de 4-oxo-pirido(2,3-d)pirimidina
MY100083A (en) Diazepinoindoles, their production and pharmaceutical compositions containing them.